4-(2-(1,3-DIOXOISOINDOLIN-2-YL)ETHYL)PHENYL PIVALATE, 95.0%, 1g

2-Vinyloxytetrahydropyran>97.0%(GC)5g

N-[4-[(4-propan-2-yloxyphenyl)methyl]phenyl]-4,5-dihydro-1H-imidazol-2-amine, 97%, 1mg

4-(3-Fluoro-phenylsulfanylmethyl)-piperidine hydrochloride, 95.0%, 100mg

1-(3-Bromo-4-methoxyphenyl)cyclopropan-1-ol, 98%, 250mg

2,8-Dichloroquinoline, 95.0%, 25g

2-[(Difluoromethyl)thio]aniline, 95.0%, 250mg

1-tert-Butyl 3-ethyl 4-ureido-1H-pyrrole-1,3(2H,5H)-dicarboxylate, 95.0%, 1g

3-cyano-3'-iodobenzophenone, 97.0%, 1g

3-(4-Bromobenzyl)-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid, 98%, 1g

2-(2,4-Dimethylphenoxy)propanohydrazide, 95.0%, 1g

4-Bromo-3-iodophenol, 98%, 250mg

Estándar de viscosidad S3, ROTI®Calipure, 4,5 cSt (20 °C), 500 ml, envase de vidrio